• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

More Quality Measures Needed for Cancer, Other Chronic Diseases

Article

Among the 20 chronic conditions with the highest impact on the Medicare population, some have no quality measure, which limits Medicare's ability to pay for value.

For many chronic conditions, including many cancer types, there are not effective quality measurements in place, which limits Medicare's ability to pay for value, according to a new assessment from Avalere. Diabetes and chronic renal disease have 21 measures each, but prostate cancer and lung cancer only have 3 measure each.

Both endometrial cancer and Alzheimer's disease, which are among the conditions with the highest impact, currently have no Medicare quality measures, Avalere reported. These high-impact conditions are prioritized based on the relative cost, prevalence, variability, improvability, disease burden, and disparities of each chronic condition to the Medicare popultion.

“As Medicare and other payers move towards value-based payments for services and pharmaceuticals, we need more meaningful quality measures in oncology and selected other areas of medicine to ensure alignment," said Dan Mendelson, Avalere CEO.

Read more at Avalere: http://bit.ly/1fxTaxO

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Hamlet Gasoyan, PhD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.